ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Willow Biosciences Inc

Willow Biosciences Inc (WLLW)

0,06
0,005
(9,09%)
Geschlossen 26 Dezember 10:12PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,06
Gebot
0,06
Fragen
0,065
Volumen
16.000
0,06 Tagesbereich 0,06
0,055 52-Wochen-Bereich 0,145
Handelsende
0,055
Handelsbeginn
0,06
Letzte Trade
1000
@
0.06
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
125.017
Finanzvolumen
-
VWAP
-

WLLW Neueste Nachrichten

WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire SUNNYVALE, Calif., Nov. 12, 2024 Company reports record revenue of $1.7 million in...

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS PORTFOLIO PR Newswire SUNNYVALE, Calif., Nov. 7, 2024...

WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT

WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT PR Newswire SUNNYVALE, Calif., Sept...

WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC.

WILLOW ANNOUNCES COMMERCIAL LICENSE AND ROYALTY AGREEMENT WITH KALSEC INC. PR Newswire SUNNYVALE, Calif., Sept. 5, 2024 The agreement with Kalsec anticipates milestone payments for finalizing...

WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire SUNNYVALE, Calif., Aug. 12, 2024 Company reports record revenue of $1.0 million, an...

WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY

WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY PR Newswire SUNNYVALE, Calif., Aug. 7, 2024 After a...

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM PR Newswire SUNNYVALE, Calif., June 26, 2024 Company announced multi-product development and...

WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS

WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS PR Newswire SUNNYVALE, Calif., May 30, 2024 Collaboration...

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire SUNNYVALE, Calif., May 13, 2024 Company continues to advance its corticosteroid...

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF

WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF PR Newswire SUNNYVALE, Calif., March 28, 2024 Completed the reorganization of...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.01-14.28571428570.070.0750.0554895200.0605107CS
4-0.02-250.080.0850.0552044690.06780243CS
12-0.04-400.10.1050.0551250170.07579449CS
26-0.05-45.45454545450.110.1450.0551098300.08700615CS
52-0.04-400.10.1450.055885820.09360387CS
156-0.36-85.71428571430.420.480.055998760.14034666CS
260-0.47-88.6792452830.532.240.0551530710.61056532CS

WLLW - Frequently Asked Questions (FAQ)

What is the current Willow Biosciences share price?
The current share price of Willow Biosciences is $ 0,06
What is the 1 year trading range for Willow Biosciences share price?
Willow Biosciences has traded in the range of $ 0,055 to $ 0,145 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GMTNGold Mountain Mining Corp
$ 0,035
(16,67%)
10k
XLYAuxly Cannabis Group Inc
$ 0,035
(16,67%)
378,93k
PPRPrairie Provident Resources Inc
$ 0,035
(16,67%)
390k
WRXWestern Resources Corp
$ 0,04
(14,29%)
3k
GFRGreenfire Resources Ltd
$ 10,09
(13,37%)
31,9k
RTGRTG Mining Inc
$ 0,025
(-37,50%)
100k
NCFNorthcliff Resources Ltd
$ 0,02
(-20,00%)
1,03M
KLSKelso Technologies Inc
$ 0,11
(-15,38%)
3,5k
AVLAvalon Advanced Materials Inc
$ 0,035
(-12,50%)
114k
YRBYorbeau Resources Inc
$ 0,035
(-12,50%)
110k
TTelus Corp
$ 19,45
(-1,52%)
4,87M
BBBlackBerry Limited
$ 5,65
(4,05%)
3,61M
ABXBarrick Gold Corporation
$ 22,55
(0,71%)
3,57M
BITFBitfarms Ltd
$ 2,45
(6,06%)
3,26M
FCUFission Uranium Corp
$ 0,72
(-2,70%)
2,54M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock